QUIDEL CORP Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 61 rows in 2022. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2022-05-27: Reporting owner Ranalli Tamara A.; Form 4; Security Non-Qualified Stock Options; Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2022-05-27: Reporting owner Ranalli Tamara A.; Form 4; Security Non-Qualified Stock Options; Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2022-05-27: Reporting owner Ranalli Tamara A.; Form 4; Security Non-Qualified Stock Options; Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2022-05-27: Reporting owner Ranalli Tamara A.; Form 4; Security Non-Qualified Stock Options; Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2022-05-27 | Ranalli Tamara A. Officer (SVP, Molecular Bus. Unit) | 4 | Non-Qualified Stock Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −3,194 0 owned after | $22.21 exercise price | 2022-06-01 | |
| 2022-05-27 | Ranalli Tamara A. Officer (SVP, Molecular Bus. Unit) | 4 | Non-Qualified Stock Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −6,360 0 owned after | $27.57 exercise price | 2022-06-01 | |
| 2022-05-27 | Ranalli Tamara A. Officer (SVP, Molecular Bus. Unit) | 4 | Non-Qualified Stock Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −3,910 0 owned after | $23.41 exercise price | 2022-06-01 | |
| 2022-05-27 | Ranalli Tamara A. Officer (SVP, Molecular Bus. Unit) | 4 | Non-Qualified Stock Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −1,954 0 owned after | $15.40 exercise price | 2022-06-01 | |
| 2022-05-27 | Ranalli Tamara A. Officer (SVP, Molecular Bus. Unit) | 4 | Non-Qualified Stock Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −1,349 0 owned after | $21.08 exercise price | 2022-06-01 | |
| 2022-05-27 | Ranalli Tamara A. Officer (SVP, Molecular Bus. Unit) | 4 | Non-Qualified Stock Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −3,455 0 owned after | $46.41 exercise price | 2022-06-01 | |
| 2022-05-27 | Ranalli Tamara A. Officer (SVP, Molecular Bus. Unit) | 4 | Non-Qualified Stock Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −3,020 0 owned after | $59.12 exercise price | 2022-06-01 | |
| 2022-05-27 | Ranalli Tamara A. Officer (SVP, Molecular Bus. Unit) | 4 | Non-Qualified Stock Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −2,372 0 owned after | $77.16 exercise price | 2022-06-01 | |
| 2022-05-27 | Ranalli Tamara A. Officer (SVP, Molecular Bus. Unit) | 4 | Non-Qualified Stock Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −1,906 0 owned after | $228.21 exercise price | 2022-06-01 | |
| 2022-05-27 | Ranalli Tamara A. Officer (SVP, Molecular Bus. Unit) | 4 | Non-Qualified Stock Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −1,892 0 owned after | $254.00 exercise price | 2022-06-01 | |
| 2022-05-27 | Ranalli Tamara A. Officer (SVP, Molecular Bus. Unit) | 4 | Non-Qualified Stock Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −4,957 0 owned after | $103.36 exercise price | 2022-06-01 | |
| 2022-05-27 | Strobeck Matthew Director | 4 | Non-Qualified Stock Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −259 0 owned after | $53.27 exercise price | 2022-06-01 | |
| 2022-05-27 | WIDDER KENNETH J Director | 4 | Non-Qualified Stock Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −3,333 0 owned after | $27.91 exercise price | 2022-06-01 | |
| 2022-05-27 | WIDDER KENNETH J Director | 4 | Non-Qualified Stock Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −7,021 0 owned after | $22.86 exercise price | 2022-06-01 | |
| 2022-05-27 | WIDDER KENNETH J Director | 4 | Non-Qualified Stock Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −7,021 0 owned after | $15.74 exercise price | 2022-06-01 | |
| 2022-05-27 | WIDDER KENNETH J Director | 4 | Non-Qualified Stock Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −5,065 0 owned after | $24.80 exercise price | 2022-06-01 | |
| 2022-05-27 | Hodges Michelle A. Officer (SVP, General Counsel) | 4 | Non-Qualified Stock Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −2,105 0 owned after | $188.95 exercise price | 2022-06-01 | |
| 2022-05-27 | Hodges Michelle A. Officer (SVP, General Counsel) | 4 | Non-Qualified Stock Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −1,892 0 owned after | $254.00 exercise price | 2022-06-01 | |
| 2022-05-27 | Hodges Michelle A. Officer (SVP, General Counsel) | 4 | Non-Qualified Stock Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −6,438 0 owned after | $103.36 exercise price | 2022-06-01 | |
| 2022-05-27 | Bujarski Robert Joseph Officer (Chief Operating Officer) | 4 | Non-Qualified Stock Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −8,798 0 owned after | $23.41 exercise price | 2022-06-01 | |
| 2022-05-27 | Bujarski Robert Joseph Officer (Chief Operating Officer) | 4 | Non-Qualified Stock Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −17,596 0 owned after | $15.40 exercise price | 2022-06-01 | |
| 2022-05-27 | Bujarski Robert Joseph Officer (Chief Operating Officer) | 4 | Non-Qualified Stock Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −14,343 0 owned after | $21.08 exercise price | 2022-06-01 | |
| 2022-05-27 | Bujarski Robert Joseph Officer (Chief Operating Officer) | 4 | Non-Qualified Stock Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −9,212 0 owned after | $46.41 exercise price | 2022-06-01 | |
| 2022-05-27 | Bujarski Robert Joseph Officer (Chief Operating Officer) | 4 | Non-Qualified Stock Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −7,246 0 owned after | $59.12 exercise price | 2022-06-01 | |
| 2022-05-27 | Bujarski Robert Joseph Officer (Chief Operating Officer) | 4 | Non-Qualified Stock Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −6,641 0 owned after | $77.16 exercise price | 2022-06-01 | |
| 2022-05-27 | Bujarski Robert Joseph Officer (Chief Operating Officer) | 4 | Non-Qualified Stock Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −2,935 0 owned after | $159.39 exercise price | 2022-06-01 | |
| 2022-05-27 | Bujarski Robert Joseph Officer (Chief Operating Officer) | 4 | Non-Qualified Stock Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −3,514 0 owned after | $254.00 exercise price | 2022-06-01 | |
| 2022-05-27 | Bujarski Robert Joseph Officer (Chief Operating Officer) | 4 | Non-Qualified Stock Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −12,876 0 owned after | $103.36 exercise price | 2022-06-01 | |
| 2022-05-27 | Kroll Werner Officer (SVP, R&D) | 4 | Non-Qualified Stock Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −2,303 0 owned after | $46.41 exercise price | 2022-06-01 | |
| 2022-05-27 | Kroll Werner Officer (SVP, R&D) | 4 | Non-Qualified Stock Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −3,924 0 owned after | $59.12 exercise price | 2022-06-01 | |
| 2022-05-27 | BUECHLER KENNETH F Director | 4 | Non-Qualified Stock Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −8,081 0 owned after | $23.70 exercise price | 2022-06-01 | |
| 2022-05-27 | BUECHLER KENNETH F Director | 4 | Non-Qualified Stock Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −9,041 0 owned after | $21.07 exercise price | 2022-06-01 | |
| 2022-05-27 | BUECHLER KENNETH F Director | 4 | Non-Qualified Stock Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −7,021 0 owned after | $22.86 exercise price | 2022-06-01 | |
| 2022-05-27 | BUECHLER KENNETH F Director | 4 | Non-Qualified Stock Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −1,811 0 owned after | $21.29 exercise price | 2022-06-01 | |
| 2022-05-27 | BUECHLER KENNETH F Director | 4 | Non-Qualified Stock Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −9,215 0 owned after | $15.74 exercise price | 2022-06-01 | |
| 2022-05-27 | BUECHLER KENNETH F Director | 4 | Non-Qualified Stock Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −5,851 0 owned after | $24.80 exercise price | 2022-06-01 | |
| 2022-05-27 | Ferenczy William J. Officer (SVP, Cardio/Metabolic Unit) | 4 | Non-Qualified Stock Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −460 0 owned after | $23.41 exercise price | 2022-06-01 | |
| 2022-05-27 | Ferenczy William J. Officer (SVP, Cardio/Metabolic Unit) | 4 | Non-Qualified Stock Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −1,349 0 owned after | $21.08 exercise price | 2022-06-01 | |
| 2022-05-27 | Ferenczy William J. Officer (SVP, Cardio/Metabolic Unit) | 4 | Non-Qualified Stock Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −1,727 0 owned after | $46.41 exercise price | 2022-06-01 | |
| 2022-05-27 | Ferenczy William J. Officer (SVP, Cardio/Metabolic Unit) | 4 | Non-Qualified Stock Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −3,322 0 owned after | $59.12 exercise price | 2022-06-01 | |
| 2022-05-27 | Ferenczy William J. Officer (SVP, Cardio/Metabolic Unit) | 4 | Non-Qualified Stock Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −2,609 0 owned after | $77.16 exercise price | 2022-06-01 | |
| 2022-05-27 | Ferenczy William J. Officer (SVP, Cardio/Metabolic Unit) | 4 | Non-Qualified Stock Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −4,685 0 owned after | $103.64 exercise price | 2022-06-01 | |
| 2022-05-27 | Ferenczy William J. Officer (SVP, Cardio/Metabolic Unit) | 4 | Non-Qualified Stock Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −1,892 0 owned after | $254.00 exercise price | 2022-06-01 | |
| 2022-05-27 | Ferenczy William J. Officer (SVP, Cardio/Metabolic Unit) | 4 | Non-Qualified Stock Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −4,957 0 owned after | $103.36 exercise price | 2022-06-01 | |
| 2022-05-27 | BRYANT DOUGLAS C Director, Officer (President & CEO) | 4 | Non-Qualified Stock Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −23,461 0 owned after | $15.40 exercise price | 2022-06-01 | |
| 2022-05-27 | BRYANT DOUGLAS C Director, Officer (President & CEO) | 4 | Non-Qualified Stock Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −20,249 0 owned after | $21.08 exercise price | 2022-06-01 | |
| 2022-05-27 | BRYANT DOUGLAS C Director, Officer (President & CEO) | 4 | Non-Qualified Stock Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −27,637 0 owned after | $46.41 exercise price | 2022-06-01 | |
| 2022-05-27 | BRYANT DOUGLAS C Director, Officer (President & CEO) | 4 | Non-Qualified Stock Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −37,440 0 owned after | $59.12 exercise price | 2022-06-01 | |
| 2022-05-27 | BRYANT DOUGLAS C Director, Officer (President & CEO) | 4 | Non-Qualified Stock Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −30,358 0 owned after | $77.16 exercise price | 2022-06-01 | |
| 2022-05-27 | BRYANT DOUGLAS C Director, Officer (President & CEO) | 4 | Non-Qualified Stock Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −10,593 0 owned after | $228.21 exercise price | 2022-06-01 | |
| 2022-05-27 | BRYANT DOUGLAS C Director, Officer (President & CEO) | 4 | Non-Qualified Stock Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −8,924 0 owned after | $254.00 exercise price | 2022-06-01 | |
| 2022-05-27 | BRYANT DOUGLAS C Director, Officer (President & CEO) | 4 | Non-Qualified Stock Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −11,140 0 owned after | $142.45 exercise price | 2022-06-01 | |
| 2022-05-27 | BRYANT DOUGLAS C Director, Officer (President & CEO) | 4 | Non-Qualified Stock Options Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −27,043 0 owned after | $103.36 exercise price | 2022-06-01 | |
| 2022-05-10 | BUECHLER KENNETH F Director | 4 | Non-Qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,800 0 owned after | $15.73 exercise price | 2022-05-12 | |
| 2022-01-31 | Ranalli Tamara A. Officer (SVP, Molecular Bus. Unit) | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,957 4,957 owned after | $103.36 exercise price | 2022-02-02 | |
| 2022-01-31 | Hodges Michelle A. Officer (SVP, General Counsel) | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,438 6,438 owned after | $103.36 exercise price | 2022-02-02 | |
| 2022-01-31 | Ferenczy William J. Officer (SVP, Cardio/Metabolic Unit) | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,957 4,957 owned after | $103.36 exercise price | 2022-02-02 | |
| 2022-01-31 | Bujarski Robert Joseph Officer (Chief Operating Officer) | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,876 12,876 owned after | $103.36 exercise price | 2022-02-02 | |
| 2022-01-31 | BRYANT DOUGLAS C Director, Officer (President & CEO) | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +27,043 27,043 owned after | $103.36 exercise price | 2022-02-02 | |
| 2022-01-25 | SLACIK CHARLES P Director | 4 | Non-Qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,021 0 owned after | $15.74 exercise price | 2022-01-27 | |
| 2022-01-25 | SLACIK CHARLES P Director | 4 | Non-Qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,065 0 owned after | $24.80 exercise price | 2022-01-27 |